The Effect of Magnesium on Post-spinal Headaches
ConditionPost-spinal Headache
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorHaseki Training and Research Hospital
About this trial
This retrospective cohort study aims to assess the effect of the use of magnesium sulphate in routine clinical practice on the development of post-dural puncture headache in patients undergoing spinal anaesthesia
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Patients aged 18-45
Patients who underwent spinal anaesthesia for elective caesarean section
Patients with an ASA physical status score of I-III
Patients in whom a 25G or 27G pencil-point needle was used for spinal anaesthesia
Disqualifiers
• Patients undergoing emergency surgery
Patients with a history of chronic headaches
Patients who have undergone unsuccessful spinal anaesthesia or multiple attempts
Patients who have undergone combined spinal-epidural anaesthesia
Trial population
In this study, which is designed as a retrospective cohort study, the records of all patients who underwent caesarean section under spinal anaesthesia at our hospital between 1 January 2025 and 31 December 2025 and who met the inclusion criteria will be reviewed.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Magnesium
Other interventionPost-spinal headache in patients receiving magnesium
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: administered intravenous magnesium1 intervention
Group B: without intravenous magnesium1 intervention
Trial outcomes
Primary outcomes
1
Incidence of post-spinal headache
the number of people who develop a headache following spinal anaesthesia
Time frame
1. daySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: